A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 10, Pages 2134
Publisher
MDPI AG
Online
2017-10-13
DOI
10.3390/ijms18102134
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells
- (2017) Theresa Relation et al. STEM CELLS
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Immune suppressive mechanisms in the tumor microenvironment
- (2016) David H Munn et al. CURRENT OPINION IN IMMUNOLOGY
- Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells
- (2016) Tze-Sian Chan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Eco-evolution of cancer resistance
- (2016) Giannoula L. Klement Science Translational Medicine
- Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition
- (2016) Irina Kareva et al. PLoS One
- Metabolism and Its Sequelae in Cancer Evolution and Therapy
- (2015) Robert J. Gillies et al. CANCER JOURNAL
- Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
- (2015) Irina Kareva et al. CANCER LETTERS
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- Cancer immunoediting: A process driven by metabolic competition as a predator–prey–shared resource type model
- (2015) Irina Kareva et al. JOURNAL OF THEORETICAL BIOLOGY
- Immune Checkpoint Inhibitors in Melanoma Provide the Cornerstones for Curative Therapies
- (2015) Alexander M.M. Eggermont et al. SEMINARS IN ONCOLOGY
- High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant
- (2015) Gillian Farnie et al. Oncotarget
- Tumors: Wounds That Do Not Heal--Redux
- (2015) H. F. Dvorak Cancer Immunology Research
- Metronomic cyclophosphamide eradicates large implanted GL261 gliomas by activating antitumor Cd8+T-cell responses and immune memory
- (2015) Junjie Wu et al. OncoImmunology
- Targeting Aggressive Cancer Stem Cells in Glioblastoma
- (2015) Tracy Seymour et al. Frontiers in Oncology
- Metronomic cyclophosphamide schedule-dependence of innate immune cell recruitment and tumor regression in an implanted glioma model
- (2014) Junjie Wu et al. CANCER LETTERS
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
- (2014) S. L. Highfill et al. Science Translational Medicine
- What Can Ecology Teach Us About Cancer?
- (2014) Irina Kareva Translational Oncology
- The Emerging "Hallmarks" of Metabolic Reprogramming and Immune Evasion: Distinct or Linked?
- (2013) I. Kareva et al. CANCER RESEARCH
- Biological Stoichiometry in Tumor Micro-environments
- (2013) Irina Kareva PLoS One
- VEGF and Notch in Tip and Stalk Cell Selection
- (2013) R. Blanco et al. Cold Spring Harbor Perspectives in Medicine
- VEGF Receptor Inhibitors Block the Ability of Metronomically Dosed Cyclophosphamide to Activate Innate Immunity-Induced Tumor Regression
- (2012) J. C. Doloff et al. CANCER RESEARCH
- Microenvironmental Regulation of Epithelial-Mesenchymal Transitions in Cancer
- (2012) D. Gao et al. CANCER RESEARCH
- Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy
- (2012) Mariana S. Nars et al. INTERNATIONAL JOURNAL OF CANCER
- CD80 and CD86 Differentially Regulate Mechanical Interactions of T-Cells with Antigen-Presenting Dendritic Cells and B-Cells
- (2012) Tong Seng Lim et al. PLoS One
- Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
- (2011) Peter Friedl et al. CELL
- Ipilimumab
- (2011) Fiona Cameron et al. DRUGS
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Prisoner's Dilemma in Cancer Metabolism
- (2011) Irina Kareva PLoS One
- Counterbalancing angiogenic regulatory factors control the rate of cancer progression and survival in a stage-specific manner
- (2011) L. Xie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2
- (2010) S. Huber et al. BLOOD
- Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma
- (2010) Ryosuke Hino et al. CANCER
- Origins and Evolution of Antibiotic Resistance
- (2010) J. Davies et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
- (2009) Claire Banissi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Classification of Chemotherapeutic Agents Based on Their Differential In vitro Effects on Dendritic Cells
- (2009) H. Tanaka et al. CANCER RESEARCH
- Immunomodulation of FOXP3+ Regulatory T Cells by the Aromatase Inhibitor Letrozole in Breast Cancer Patients
- (2009) D. Generali et al. CLINICAL CANCER RESEARCH
- Dominant Effect of Antiangiogenesis in Combination Therapy Involving Cyclophosphamide and Axitinib
- (2009) J. Ma et al. CLINICAL CANCER RESEARCH
- Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
- (2009) Brian T Fife et al. NATURE IMMUNOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- A History of Cancer Chemotherapy
- (2008) Vincent T. DeVita et al. CANCER RESEARCH
- Tumor dormancy due to failure of angiogenesis: role of the microenvironment
- (2008) George N. Naumov et al. CLINICAL & EXPERIMENTAL METASTASIS
- Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways
- (2008) Brian T. Fife et al. IMMUNOLOGICAL REVIEWS
- Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival
- (2008) Nancie J. MacIver et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Combination of antiangiogenesis with chemotherapy for more effective cancer treatment
- (2008) J. Ma et al. MOLECULAR CANCER THERAPEUTICS
- Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond
- (2008) Vadivel Ganapathy et al. PHARMACOLOGY & THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now